Make a one-page reference card on pterygium definition etiology pathogenesis clinical features diagnosis and treatment with diagram

Reading File
Finding Sources
Searching the Web

pterygium eye definition etiology pathogenesis clinical features diagnosis treatment

Reading File
Reading File
Finding Sources
Reading File
Loading Image
Loading Image
Generating Image

A detailed one-page medical reference card titled "PTERYGIUM - Quick Reference Card" for ophthalmology students and clinicians. The card is structured in clean, color-coded sections on a white background with a professional medical layout. Include the following sections clearly labeled: 1. DEFINITION (blue header): "Triangular fibrovascular sub-epithelial ingrowth of degenerative bulbar conjunctival tissue over the limbus onto the cornea. From Greek 'pterygos' = wing. Also called Surfer's Eye." 2. ETIOLOGY (green header): UV radiation (most important), dry/dusty/windy environments, geographic - equatorial regions, genetic predisposition, chronic ocular surface dryness, low latitude residence 3. PATHOGENESIS (orange header): UV-induced limbal stem cell damage → elastotic degeneration of subepithelial stromal collagen → fibrovascular proliferation → invasion of Bowman layer → corneal encroachment. P53 mutation, MMP upregulation, VEGF-mediated neovascularization 4. PARTS DIAGRAM: A clear labeled anatomical diagram of pterygium showing the three parts: CAP (avascular halo at advancing edge), HEAD (invades cornea), BODY (on conjunctiva, vascularized). Also label Stocker line (iron deposition) and Fuchs islets. Include a simple wing-shaped triangle overlaid on an eye schematic showing nasal location. 5. CLINICAL FEATURES (purple header): Symptoms: irritation/grittiness, foreign body sensation, redness, reduced vision (axis obscuration or astigmatism), cosmetic concern. Signs: wing-shaped fibrovascular growth at 3 or 9 o'clock (nasal > temporal), Stocker line (iron deposition in corneal epithelium), Fuchs islets, dellen effect 6. DIAGNOSIS (teal header): Clinical - slit-lamp examination. Grading: Grade I (episcleral vessels visible), Grade II (vessels partially obscured), Grade III (vessels fully obscured). Rule out: CIN (conjunctival intraepithelial neoplasia), pseudopterygium, limbal dermoid. Biopsy for atypical lesions. 7. TREATMENT (red header): - Medical: lubricants, topical steroids, UV-protective sunglasses - Surgery: INDICATIONS - visual axis encroachment, induced astigmatism, motility restriction, cosmesis - Techniques: Bare sclera (high recurrence ~80%) | Conjunctival autograft (gold standard, recurrence 2-40%) | Amniotic membrane graft (recurrence 2.6-10.7%) - Adjuvants: Mitomycin C, beta-irradiation (reduce recurrence) 8. KEY FACTS BOX (yellow): Pseudopterygium - attached only at apex; passes probe test. Stocker line = iron deposition. Avoid bare sclera alone. Recurrence risk reduced by conjunctival autograft + MMC. The card should look professional, use colored section boxes, include the anatomical parts diagram prominently, and fit all content on one page in a visually organized two-column layout.

Pterygium Reference Card

Here is the complete one-page reference card. Below is the full structured content for study/printing:

PTERYGIUM - Quick Reference Card

DEFINITION

A triangular fibrovascular sub-epithelial ingrowth of degenerative bulbar conjunctival tissue over the limbus onto the cornea. From Greek pterygos = "wing." Also called Surfer's Eye. Located within the interpalpebral fissure, almost always at the nasal limbus (3 or 9 o'clock position).
  • Kanski's Clinical Ophthalmology, p.215

ETIOLOGY

FactorDetails
UV radiationMost important; cumulative exposure damages limbal stem cells
GeographicHigher prevalence near equator; <2% above 40th parallel vs 5-15% at 28-36° latitude
EnvironmentalChronic dryness, dust, wind, heat
GeneticTends to run in families
OccupationOutdoor workers, farmers, fishermen, surfers

PATHOGENESIS

UV light → limbal stem cell dysfunction → subepithelial elastotic collagen degeneration → fibrovascular proliferation → invasion of Bowman layer → progressive corneal encroachment
Molecular mediators: p53 mutation, MMP upregulation, VEGF-driven neovascularization, loss of Wnt signaling regulation.

ANATOMY OF PTERYGIUM (Three Parts)

[ BODY ]──────[ HEAD ]──[ CAP ]─ → cornea
(vascularized  (invades   (avascular
conjunctival)   cornea)    advancing edge)
        ↑ Stocker line (iron deposition ahead of cap)
        ↑ Fuchs islets (discrete epithelial cell clusters at edge)
Histology: Elastotic degeneration of vascularized subepithelial stromal collagen (seen in image A above from Kanski's).

CLINICAL FEATURES

Symptoms:
  • Small lesions: often asymptomatic
  • Irritation, grittiness (dellen effect - localized tear film disruption)
  • Foreign body sensation
  • Redness / intermittent inflammation (pterygitis)
  • Reduced vision (axis encroachment or induced astigmatism)
  • Contact lens intolerance
  • Cosmetic concern
Signs:
  • Wing-shaped pink-red fibrovascular growth, nasal > temporal
  • Stocker line - linear iron deposition in corneal epithelium anterior to head
  • Fuchs islets at advancing edge
  • Dellen (corneal thinning adjacent to elevated head)
  • Advanced: subconjunctival fibrosis, restricted ocular excursion
Grading:
GradeScleral Vessels
I (atrophic)Clearly visible through pterygium
II (intermediate)Partially obscured
III (fleshy)Completely obscured

DIAGNOSIS

  • Clinical: Slit-lamp examination - characteristic location, wing-shape, slit-beam assessment of depth
  • Topography/Keratometry: Assess induced astigmatism
  • Biopsy: For atypical pterygia to exclude Conjunctival Intraepithelial Neoplasia (CIN)
Differential Diagnosis:
  • Pseudopterygium - attached only at apex (probe can pass under body); associated with prior trauma/burn/ulcer
  • CIN - papillomatous, velvety, not necessarily 3 or 9 o'clock
  • Limbal dermoid
  • Pinguecula (does not encroach onto cornea)

TREATMENT

Medical (symptomatic relief):
  • Artificial tears / lubricants
  • Topical steroids (short course for inflammation)
  • UV-protective sunglasses (primary prevention)
Surgical Indications:
  • Encroachment toward visual axis
  • Significant induced astigmatism
  • Restricted ocular motility
  • Cosmesis / recurrent inflammation unresponsive to drops
Surgical Techniques:
TechniqueRecurrence RateNotes
Bare sclera excision~80%Not recommended alone
Conjunctival autograft2-40% (gold standard)Harvested from superior/upper temporal limbus; can use fibrin glue (TISSEEL) instead of sutures
Amniotic membrane graft2.6-10.7% (primary); up to 37.5% (recurrent)Preserves bulbar conjunctiva
Adjuvant therapy:
  • Mitomycin C (MMC) - antifibrotic, inhibits fibroblasts; applied intraoperatively
  • Beta-irradiation - reduces recurrence
  • Peripheral lamellar keratoplasty - for deep lesions
TIP (Kanski's): Recurrence risk is best reduced by conjunctival autograft + MMC application.

CLINICAL IMAGES (from Kanski's, Fig. 6.28)

Fig 6.28 Pterygium - Histology (A), pterygium with cap/head/body and Stocker line (B), inflamed pterygium (C), pseudopterygium post-chemical burn (D)
A = Histology (elastotic collagen degeneration) | B = Classic pterygium with Stocker line (arrow) | C = Inflamed pterygium | D = Pseudopterygium post-chemical burn
Early pterygium - Wills Eye Manual Fig 4.9.1
Early nasal pterygium (Wills Eye Manual, Fig. 4.9.1)

Sources: Kanski's Clinical Ophthalmology (10th ed.), Wills Eye Manual, Rosen's Emergency Medicine - pterygium sections.
This is a shared conversation. Sign in to Orris to start your own chat.